PHARMACY

Lupin introduces generic Rapaflo
Lupin rolls out generic Rapaflo, which had a market value of about $198.5 million.
FDA gives Lupin's generic Eliquis tentative approval
The FDA has given tentative clearance for Lupin's generic Eliquis, which had a market value of about $6.4 billion.

HFAP unveils compounding pharmacy certification

HFAP's compounding pharmacy certification program ensures high standards of quality.
Sun Pharma gets FDA green light for generic Ganirelix

The Food and Drug Administration has cleared Sun Pharma's generic Ganirelix, which had a market value of about $67 million, according to IQVIA data.
Albertsons bridges pharmacy, store to build health focus

Albertsons manages to undertake a big-picture wellness play by bringing together the grocery aisles with its pharmacy offerings.
Rite Aid Foundation brings Prescription Drug Safety Initiative to Scranton

The Rite Aid Foundation's efforts to help address adolescent drug abuse and misuse will bring the Prescription Drug Safety program to Scranton, Pa.-area high schools.
Hikma launches generic Onfi

Hikma is offering clobazam oral suspension and clobazam tablets, which had a market value of $260 million and $601 million respectively.
FDA issues draft guidance to ensure safety of compounded drugs

The FDA's revised draft guidance aims to protect patients from contaminated or substandard compounded drugs.
Presidential historian Doris Kearns Goodwin to address NACDS Annual Meeting

NACDS Annual Meeting attendees will glean insights from renowned presidential historian Doris Kearns Goodwin.
FDA partners with WHO to expedite review of HIV drug applications

The Food and Drug Administration and World Health Organization are launching a pilot called the Collaborative Registration Procedure-Lite to expedite HIV drug applications.